SEC Form 4 · accession 0001193125-26-394390
BioStem Technologies, Inc. · BSEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Howard Warrington Jr.
Director
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001658678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2026 | M | 1,694 | $0.00 | A | 33,928 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Sep 15, 2026 | M | 1,694 | D | — | — | Common Stock | 1,694 | 6,773 | D |
| Options (Right to Buy)F1 | $1.80 | holding | — | — | — | — | Mar 29, 2032 | Common Stock | 7,462 | 7,462 | D |
Explanation of responses
- F1These options are fully vested and exercisable.
- F2Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F3These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).